Results 11 to 20 of about 13,429 (224)
Emerging Microbes and Infections, 2018 H7N9 influenza viruses emerged in 2013 and have caused severe disease and deaths in humans in China. Some H7N9 viruses circulating in chickens have mutated to highly pathogenic viruses that have caused several disease outbreaks in chickens.
Wenyu Yang +8 more
doaj +2 more sources
Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
Pharmaceuticals, 2022 Influenza outbreaks caused by A/H7N9 viruses have occurred since 2013. After 2016, A/H7N9 influenza viruses underwent evolutionary changes. In this study, we examined the antigenic properties of influenza neuraminidase (NA) of A/H7N9 viruses as part of a
Yulia Desheva +7 more
doaj +2 more sources
Early responses to H7N9 in southern Mainland China [PDF]
BMC Infectious Diseases, 2014 H7N9 posed potentially serious health challenges for Chinese society. The previous SARS outbreak in this country was accompanied by contradictory information, while worries about wide-spread influenza led to discrimination worldwide. Early understanding of public threat perceptions is therefore important for effective public health communication and ...
Goodwin, R, Sun, S
openaire +7 more sources
Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice
mBio, 2013 A novel avian-origin influenza A/H7N9 virus infecting humans was first identified in March 2013 and, as of 30 May 2013, has caused 132 human infections leading to 33 deaths.
Chris Ka Pun Mok +8 more
doaj +2 more sources
Vaccines, 2022 Background: Short peptide hydrogel was reported as a possible adjuvant for vaccines. In order to evaluate whether the Tetra-Peptide Hydrogel can be a promising adjuvant for an H7N9 vaccine against the highly pathogenic H7N9 virus, we conducted this study.
Xiaoxin Wu +11 more
doaj +2 more sources
Emerging Infectious Diseases, 2018 The recent emergence of highly pathogenic influenza A(H7N9) variants poses a great risk to humans. We show that ferrets vaccinated with low pathogenicity H7N9 virus vaccine do not develop severe symptoms after infection with an antigenically distinct ...
Masato Hatta +5 more
doaj +2 more sources
Virology Journal, 2019 Background Since H7N9 influenza A virus (H7N9) was first reported in 2013, five waves of outbreaks have occurred, posing a huge threat to human health.
Ai-jun Chen +7 more
doaj +2 more sources
Molecular Docking of Potential Inhibitors for Influenza H7N9 [PDF]
Computational and Mathematical Methods in Medicine, 2015 As a new strain of virus emerged in 2013, avian influenza A (H7N9) virus is a threat to the public health, due to its high lethality and pathogenicity. Furthermore, H7N9 has already generated various mutations such as neuraminidase R294K mutation which could make the anti-influenza oseltamivir less effective or ineffective. In this regard, it is urgent
Liu, Zekun +8 more
openaire +5 more sources
Seasonality of avian influenza A(H7N9) activity and risk of human A(H7N9) infections from live poultry markets [PDF]
Journal of Infection, 2015 Seasonality of avian influenza A(H7N9) activity and risk of human A(H7N9) infections from live poultry ...
Lin, J +12 more
core +6 more sources
The Novel H7N9 Influenza A Virus NS1 Induces p53-Mediated Apoptosis of A549 Cells [PDF]
Cellular Physiology and Biochemistry, 2016 Background: H7N9, emerged as an avian influenza virus outbreak in Eastern China in early 2013, and represented another major threat to global health. Roles of its NS1 protein, an essential viral factor, in regulating apoptosis remain unknown.
Yinxia Yan +5 more
doaj +2 more sources